Misdiagnosis Common for Suspected Myelodysplastic Neoplasms
About one-third of cases were reclassified following central review; receipt of inappropriate meds reported in 7 percent of misdiagnosed cases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.